| Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using US Administrative Claims Data |
20 |
| Factors Affecting Health Care Provider Knowledge and Acceptance of Biosimilar Medicines: A Systematic Review |
16 |
| Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration |
16 |
| Burden of Illness in Type 2 Diabetes Mellitus |
15 |
| Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease |
13 |
| The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies |
13 |
| Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2-Advanced or Metastatic Breast Cancer: A US Payer Perspective |
12 |
| Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database |
11 |
| Integrating Innovative Telehealth Solutions into an Interprofessional Team-Delivered Chronic Care Management Pilot Program |
10 |
| Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products |
10 |
| Prospective Service Use and Health Care Costs of Medicaid Beneficiaries with Treatment-Resistant Depression |
10 |
| Value-Based Pricing for Emerging Gene Therapies: The Economic Case for a Higher Cost-Effectiveness Threshold |
10 |
| Optimizing the Role of Community Pharmacists in Managing the Health of Populations: Barriers, Facilitators, and Policy Recommendations |
10 |
| Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System |
9 |
| Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia |
9 |
| Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort |
8 |
| Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis |
8 |
| Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum-Sensitive Recurrent Ovarian Cancer |
8 |
| Economic Burden of Treatment-Resistant Depression on the US Health Care System |
8 |
| Using Previous Medication Adherence to Predict Future Adherence |
8 |
| Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the US Department of Defense Population |
7 |
| Variation in Medication Therapy Management Delivery: Implications for Health Care Policy |
7 |
| Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors |
7 |
| Intravitreal Aflibercept Versus Ranibizumab for Wet Age-Related Macular Degeneration: A Cost-Effectiveness Analysis |
7 |
| Effects of Medication Nonadherence and Comorbidity on Health Resource Utilization in Schizophrenia |
7 |
| An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a US Payer Perspective |
7 |
| Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015 |
7 |
| Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States |
6 |
| Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs |
6 |
| Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease |
6 |
| Oncologists' Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National Survey |
6 |
| Health Care Utilization and Cost Associated with Biologic Treatment Patterns Among Patients with Moderate to Severe Psoriasis: Analyses from a Large US Claims Database |
6 |
| Adherence, Persistence, and Expenditures for High-Cost Anti-Inflammatory Drugs in Rheumatoid Arthritis: An Exploratory Study |
6 |
| Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients |
6 |
| Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population |
6 |
| Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis |
6 |
| Michigan Pharmacists Transforming Care and Quality: Developing a Statewide Collaborative of Physician Organizations and Pharmacists to Improve Quality of Care and Reduce Costs |
6 |
| Evaluation of an Academic-Community Partnership to Implement MTM Services in Rural Communities to Improve Pharmaceutical Care for Patients with Diabetes and/or Hypertension |
6 |
| Real-World Health Plan Data Analysis: Key Trends in Medication Adherence and Overall Costs in Patients with HIV |
5 |
| AMCP Partnership Forum: Designing Benefits and Payment Models for Innovative High-Investment Medications |
5 |
| A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the US Medicare Population |
5 |
| Budget Impact Analysis of a Pharmacist-Provided Transition of Care Program |
5 |
| Failure of a Best Practice Alert to Reduce Antibiotic Prescribing Rates for Acute Sinusitis Across an Integrated Health System in the Midwest |
5 |
| Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV |
5 |
| Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan |
5 |
| Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence |
5 |
| Predicting Diagnosis of Alzheimer's Disease and Related Dementias Using Administrative Claims |
5 |
| Real-World Health Care Costs Based on Medication Adherence and Risk of Stroke and Bleeding in Patients Treated with Novel Anticoagulant Therapy |
5 |
| The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home |
5 |
| Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database |
5 |
